LEGN (Legend Biotech) Construction In Progress : $0.4 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Construction In Progress?

Legend Biotech's quarterly construction in progress declined from Mar. 2024 ($0.6 Mil) to Jun. 2024 ($0.3 Mil) but then increased from Jun. 2024 ($0.3 Mil) to Sep. 2024 ($0.4 Mil).

Legend Biotech's annual construction in progress declined from Dec. 2021 ($43.5 Mil) to Dec. 2022 ($15.1 Mil) and declined from Dec. 2022 ($15.1 Mil) to Dec. 2023 ($3.5 Mil).

Legend Biotech Construction In Progress Historical Data

The historical data trend for Legend Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Construction In Progress Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

10.80

28.04

43.54

15.10

3.49

Legend Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Construction In Progress	Get a 7-Day Free Trial															0.42	3.49	0.56	0.30	0.38

Legend Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Legend Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.